{"doi":"10.1007/978-981-10-6020-5_8","title":"Disrupting Tumor Angiogenesis and “the Hunger Games” for Breast Cancer","abstract":null,"journal":"Advances in Experimental Medicine and Biology","year":2017,"id":597219,"datarank":0.42498200160843247,"base_score":2.833213344056216,"endowment":2.833213344056216,"self_citation_contribution":0.42498200160843247,"citation_network_contribution":0.0,"self_endowment_contribution":0.42498200160843247,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":16,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1529961,"name":"Herui Yao","orcid":null,"position":1,"is_corresponding":false},{"id":241447,"name":"Hai Hu","orcid":"0000-0002-6985-8959","position":2,"is_corresponding":false},{"id":1239362,"name":"Ziwei Zhou","orcid":"0000-0002-5927-7835","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Disrupting Tumor Angiogenesis and “the Hunger Games” for Breast Cancer","abstract":"Angiogenesis, one of the hallmarks of cancers, has become an attractive target for cancer therapy since decades ago. It is broadly thought that upregulation of angiogenesis is involved in tumor progression and metastasis. Though tumor vessels are tortuous, disorganized, and leaky, they deliver oxygen and nutrients for tumor development. Based on this knowledge, many kinds of drugs targeting angiogenesis pathways have been developed, such as bevacizumab. However, the clinical outcomes of anti-angiogenesis therapies are moderate in metastatic breast cancer as well as in metastatic colorectal cancer and non-small cell lung cancer, even combined with traditional chemotherapy. In this chapter, the morphologic angiogenesis patterns and the key molecular pathways regulating angiogenesis are elaborated. The FDA-approved anti-angiogenesis drugs and current challenges of anti-angiogenesis therapy are described. The strategies to overcome the barriers will also be elucidated.","is_dataset_classified":null,"base_score":2.833213344056216,"endowment":2.833213344056216,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"29282684","pmcid":null,"openalex_id":"https://openalex.org/W2776883997","authors":[],"funders":[],"total_grants":0,"fwci":1.9773,"citation_percentile":0.87350835,"influential_citations":0,"citation_trend":[{"year":2019,"count":3},{"year":2020,"count":2},{"year":2021,"count":2},{"year":2022,"count":3},{"year":2023,"count":3},{"year":2025,"count":2},{"year":2026,"count":1}],"oa_status":"closed","license":"http://www.springer.com/tdm","oa_locations":[{"url":"http://link.springer.com/content/pdf/10.1007/978-981-10-6020-5_8","host_type":"publisher"},{"url":"https://doi.org/10.1007/978-981-10-6020-5_8","host_type":"book series"},{"url":"https://pubmed.ncbi.nlm.nih.gov/29282684","host_type":"repository"}],"fields_of_study":["Angiogenesis and VEGF in Cancer","Cancer, Hypoxia, and Metabolism","Cancer, Lipids, and Metabolism","Angiogenesis Inhibitors","Antibodies, Monoclonal","Bevacizumab","Breast Neoplasms","Female","Humans","Immunotherapy","Neoplasm Metastasis","Neovascularization, Pathologic"],"mesh_terms":["Bevacizumab","Antibodies, Monoclonal","Breast Neoplasms","Female","Humans","Immunotherapy","Neoplasm Metastasis","Neovascularization, Pathologic","Angiogenesis Inhibitors"],"keywords":["Angiogenesis","Bevacizumab","Metastasis","Medicine","Cancer","Cancer research","Breast cancer","Metastatic breast cancer","Colorectal cancer","Oncology","Chemotherapy","Immunology","Internal medicine","VEGF","Anti-angiogenesis Therapy"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Zero hunger"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-07-28T12:39:41.328651Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}